[Translation] An open, dose-escalating phase I clinical trial of the tolerability and safety of single-dose Yiru Tiaojing granules in healthy female volunteers
评估在健康女性志愿者中,单次口服抑乳调经颗粒10 g、20 g、30 g、 或 40 g 后的安全性和耐受性。
[Translation]
To evaluate the safety and tolerability of a single oral administration of 10 g, 20 g, 30 g, or 40 g of Inhibiting Lactation and Regulating Menstruation Granules in healthy female volunteers.
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.